Vaxcell-Bio Therapeutics Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 5, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	220,712	239,819	516,197	519,865	660,678	2,517,196
Market Cap Growth	-12.34%	-53.54%	-0.71%	-21.31%	-73.75%	-
Enterprise Value	182,668	192,973	504,030	497,951	646,323	2,482,604
Last Close Price	9490.00	10430.00	22450.00	26694.20	33924.69	130774.23
PS Ratio	-	126.29	37614.61	-	-	-
PB Ratio	-	3.33	6.18	22.29	21.96	72.61
P/TBV Ratio	-	3.57	6.20	22.51	22.07	72.75
EV/Sales Ratio	-	101.62	36727.98	-	-	-
Debt / Equity Ratio	0.03	0.03	0.00	0.01	0.01	0.01
Asset Turnover	0.02	0.02	0	-	-	-
Inventory Turnover	9.19	9.19	-	-	-	-
Quick Ratio	13.45	13.45	54.78	67.10	70.51	31.98
Current Ratio	13.87	13.87	55.43	68.06	71.88	32.29
Return on Equity (ROE)	-13.66%	-13.66%	-19.24%	-25.56%	-14.71%	-18.22%
Return on Assets (ROA)	-11.64%	-11.64%	-13.18%	-18.52%	-11.05%	-11.68%
Return on Invested Capital (ROIC)	-11.92%	-11.92%	-13.41%	-19.11%	-11.30%	-11.94%
Earnings Yield	-	-4.43%	-1.99%	-1.31%	-0.72%	-0.16%
FCF Yield	-	-5.35%	-1.86%	-1.20%	-1.03%	-0.13%
Buyback Yield / Dilution	-17.03%	-17.03%	-28.80%	-0.68%	-122.02%	-55.35%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.